Status:
UNKNOWN
Study on the Efficacy of HE and Therapeutic Group Factors on CR and QoL
Lead Sponsor:
Universidad de Extremadura
Collaborating Sponsors:
European Regional Development Fund
Conditions:
Cardiac Rehabilitation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This randomised study evaluates the efficacy of health education and therapeutic group factors on cardiac rehabilitation and quality of life in coronary patients attending cardiac rehabilitation progr...
Detailed Description
Cardiac rehabilitation has been shown to be effective in improving the quality of life of patients who have suffered a cardiovascular event, as well as in preventing future cardiovascular events, demo...
Eligibility Criteria
Inclusion
- Diagnosis of coronary heart disease, referred to the "Cardiac Prevention and Rehabilitation Unit".
Exclusion
- Patients with disabling psychiatric disorders.
- Existence of pacemaker or automatic defibrillator.
- Presence of pregnancy or breastfeeding.
- Presence of medical conditions related to oncological conditions requiring chronic treatment with drugs or other substances.
- Any condition that, in the opinion of the investigators, would disqualify the subject from participation in the study.
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 16 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06127537
Start Date
October 1 2021
End Date
June 16 2024
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Servicio Extremeño de Salud
Badajoz, Spain, 06006